These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Uricostatic effect of allopurinol in the allantoxanamide-treated rat: a new method for evaluating antiuricopathic drugs. Hropot M, Muschaweck R, Klaus E. Adv Exp Med Biol; 1984; 165 Pt A():175-8. PubMed ID: 6720375 [No Abstract] [Full Text] [Related]
5. Decreasing effect of allantoxanamide, a hyperuricemic agent on renal functions in rats. Yonetani Y, Iwaki K, Ogawa Y. Jpn J Pharmacol; 1987 Sep; 45(1):37-43. PubMed ID: 3119902 [Abstract] [Full Text] [Related]
6. Effect of fructose administration on serum urate levels in the uricase inhibited rat. Stavric B, Johnson WJ, Clayman S, Gadd RE, Chartrand A. Experientia; 1976 Mar 15; 32(3):373-4. PubMed ID: 1253916 [No Abstract] [Full Text] [Related]
7. Platelet aggregation in rats made hyperuricaemic with nucleic adid-rich diets containing oxonate, and inhibitor of uricase [proceedings]. Winocour PD, Munday KA, Taylor TG, Tuner MR. Proc Nutr Soc; 1976 Sep 15; 35(2):54A-55A. PubMed ID: 972878 [No Abstract] [Full Text] [Related]
8. Pharmacological effects of 1,3,5-triazines and their excretion characteristics in the rat. Hropot M, Sörgel F, von Kerékjártó B, Lang HJ, Muschaweck R. Adv Exp Med Biol; 1980 Sep 15; 122A():269-76. PubMed ID: 6893515 [No Abstract] [Full Text] [Related]
9. Uric acid kidney stones induced in rats by oxonic acid, a uricase inhibitor. Stavric B, Nera EA, Johnson WJ, Salem FA. Invest Urol; 1973 Jul 15; 11(1):3-8. PubMed ID: 4724271 [No Abstract] [Full Text] [Related]
10. Sites of urate transport in the rat nephron. Greger R, Lang F, Deetjen P, Knox FG. Adv Exp Med Biol; 1977 Jul 15; 76B():90-9. PubMed ID: 855767 [No Abstract] [Full Text] [Related]
11. Uricase inhibition in the rat by s-triazines: an animal model for hyperuricemia and hyperuricosuria. Johnson WJ, Stavric B, Chartrand A. Proc Soc Exp Biol Med; 1969 May 15; 131(1):8-12. PubMed ID: 5770131 [No Abstract] [Full Text] [Related]
12. Uric acid nephropathy in shocked rats after blocking of uricase activity with triazine compounds. Boda D, Pénzes P, Gecse A, Streitman K, Zsilinszky E, Karády I. Can J Physiol Pharmacol; 1973 Jun 15; 51(6):496-8. PubMed ID: 4727817 [No Abstract] [Full Text] [Related]
13. Diurnal variation in serum uric acid of rats fed potassium oxonate. Newburger J, Combs AB, Hsu TF. Drug Chem Toxicol; 1978 Jun 15; 1(3):231-5. PubMed ID: 573681 [Abstract] [Full Text] [Related]
14. Diet-induced hyperuricaemia and platelet aggregation in rats. Winocour PD, Munday KA, Taylor TG, Turner MR. Proc Nutr Soc; 1977 Sep 15; 36(2):86A. PubMed ID: 905317 [No Abstract] [Full Text] [Related]
15. Use of the uricase-inhibited rat as an animal model in toxicology. Stavric B, Nera EA. Clin Toxicol; 1978 Sep 15; 13(1):47-74. PubMed ID: 367691 [Abstract] [Full Text] [Related]
16. Uric acid-induced decrease in rat insulin secretion. Scott FW, Trick KD, Stavric B, Braaten JT, Siddiqui Y. Proc Soc Exp Biol Med; 1981 Jan 15; 166(1):123-8. PubMed ID: 7008054 [No Abstract] [Full Text] [Related]
17. Urate-oxidase in liver of oxonic acid treated mice. Otta ME, Bertini F. Acta Physiol Lat Am; 1978 Jan 15; 28(1):33-9. PubMed ID: 263154 [Abstract] [Full Text] [Related]
18. Low uricase activity in the Dalmatian dog simulated in mongrels given oxonic acid. Yü TF, Gutman AB, Berger L, Kaung C. Am J Physiol; 1971 Apr 15; 220(4):973-9. PubMed ID: 5551153 [No Abstract] [Full Text] [Related]